Company / Cash & Equivalents
SOLIGENIX, INC. Cash & Equivalents History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$26.0M
FY2021
5-year range
$26.0M / $26.0M
FY2017-FY2021
Trend
+380.5%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents changed +380% YoY in FY2021, a notable deviation from the 5-year average annual change of +85%.
Based on SEC 10-K filings.
$26M in FY2021 with a 5-year CAGR of +39.5%.
Improved from $9M to $26M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +49.4%
- 5-Year CAGR
- +39.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +39.5%, indicating consistent growth.
- In FY2021, cash & equivalents increased 380.5% year-over-year.
- Lowest cash & equivalents in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $26.0M | +380.5% |
| FY2020 | $5.4M | -39.7% |
| FY2019 | $9.0M | +15.0% |
| FY2018 | $7.8M | -11.0% |
| FY2017 | $8.8M | +78.2% |
| FY2016 | $4.9M | -10.9% |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026